🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/09/2016 | 71,99 | 72,13 | 70,97 | 71,79 | -0,28% | 1,62% | 335.989 |
| 14/09/2016 | 69,93 | 72,05 | 69,91 | 71,99 | +3,46% | 3,06% | 703.717 |
| 13/09/2016 | 70,32 | 70,80 | 68,94 | 69,58 | -1,93% | 2,65% | 622.605 |
| 12/09/2016 | 68,94 | 71,06 | 68,68 | 70,95 | +2,63% | 3,45% | 431.207 |
| 09/09/2016 | 70,36 | 70,62 | 68,72 | 69,13 | -3,00% | 2,70% | 611.224 |
| 08/09/2016 | 71,05 | 71,71 | 69,74 | 71,27 | -0,01% | 2,77% | 430.886 |
| 07/09/2016 | 68,65 | 72,93 | 68,65 | 71,28 | +5,76% | 6,23% | 1.081.544 |
| 06/09/2016 | 66,64 | 67,97 | 66,35 | 67,40 | +1,74% | 2,42% | 576.599 |
| 02/09/2016 | 66,96 | 67,53 | 66,05 | 66,24 | -0,79% | 2,21% | 575.317 |
| 01/09/2016 | 64,75 | 66,96 | 64,26 | 66,77 | +3,61% | 4,16% | 651.459 |
| 31/08/2016 | 64,78 | 64,83 | 63,74 | 64,45 | -0,96% | 1,69% | 476.572 |
| 30/08/2016 | 64,57 | 65,15 | 63,94 | 65,07 | +0,87% | 1,86% | 596.957 |
| 29/08/2016 | 64,53 | 65,50 | 64,17 | 64,51 | -0,14% | 2,06% | 415.177 |
| 26/08/2016 | 64,52 | 66,36 | 63,78 | 64,60 | -0,10% | 3,99% | 419.185 |
| 25/08/2016 | 63,26 | 66,12 | 63,01 | 64,66 | +1,22% | 4,92% | 755.654 |
| 24/08/2016 | 67,64 | 67,98 | 63,44 | 63,88 | -5,25% | 6,71% | 892.871 |
| 23/08/2016 | 66,16 | 67,74 | 66,16 | 67,42 | +1,17% | 2,39% | 472.244 |
| 22/08/2016 | 66,18 | 67,25 | 66,12 | 66,64 | +0,32% | 1,71% | 696.343 |
| 19/08/2016 | 66,80 | 67,03 | 66,18 | 66,43 | -1,03% | 1,28% | 599.682 |
| 18/08/2016 | 67,87 | 67,94 | 66,87 | 67,12 | -0,92% | 1,57% | 427.520 |
| 17/08/2016 | 69,44 | 69,44 | 66,93 | 67,74 | -2,10% | 3,61% | 694.259 |
| 16/08/2016 | 70,61 | 70,65 | 68,88 | 69,20 | -2,25% | 2,50% | 468.236 |
| 15/08/2016 | 71,13 | 71,58 | 70,62 | 70,79 | -0,41% | 1,35% | 449.161 |
| 12/08/2016 | 71,07 | 71,93 | 70,75 | 71,08 | -0,67% | 1,67% | 433.291 |
| 11/08/2016 | 70,77 | 72,23 | 70,34 | 71,56 | +1,20% | 2,66% | 667.329 |
| 10/08/2016 | 71,52 | 71,87 | 70,51 | 70,71 | -1,94% | 1,89% | 628.697 |
| 09/08/2016 | 72,66 | 72,99 | 71,74 | 72,11 | -1,59% | 1,72% | 890.947 |
| 08/08/2016 | 76,89 | 77,31 | 73,08 | 73,28 | -4,74% | 5,49% | 1.144.221 |
| 05/08/2016 | 81,10 | 81,14 | 74,34 | 76,92 | -6,88% | 8,38% | 2.110.029 |
| 04/08/2016 | 83,51 | 85,24 | 81,73 | 82,60 | -0,55% | 4,20% | 859.529 |